A Case Report on Neonatal Giant Hepatic Hemangioma
Nadia Mebrouk
*
Medicine and Neonatal Resuscitation Service, Reference National Center for Neonatology and Nutrition of Rabat, Children's Hospital Rabat, Morocco.
Amina Barkat
Medicine and Neonatal Resuscitation Service, Reference National Center for Neonatology and Nutrition of Rabat, Children's Hospital Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Hepatic hemangioma is the third most common pediatric tumor, and it is rare in the neonatal period. Because of its rarity, a treatment strategy for this disease is still being established.
Patient and Methods: A neonate girl was referred to our unit for hepatomegaly. She had a very high Alpha-fetoproteins, and the abdominal scan showed a large mass with no vascular invasion nor deep lymphadenopathy. She was diagnosed with hepatic hemangioma and treated successfully with propranolol and cortisone. After 17 months of treatment, the patient’s hepatomegaly was reduced by 97.3%.
Results: Report on successful treatment, with no side effects, for hepatic hemangioma with propranolol and cortisone associated with calcium, potassium, and vitamin D.
Conclusion: The patient’s large focal hepatic hemangioma was treated successfully with propranolol. The treatment included cortisone for one month, associated with calcium, potassium, and vitamin D.
Keywords: Infantile hepatic hemangioma, propranolol, corticosteroids